Abbott Japan Takes Over Marketing Approval for Duphaston from Daiichi Sankyo

April 2, 2014
Abbott Japan took over the marketing approval for the retro-progesterone preparation Duphaston Tablets 5 mg (dydrogesterone) from Daiichi Sankyo on April 1. Duphaston obtained approval in Japan in 1965. It is indicated for the treatment of threatened abortion, habitual abortion,...read more